Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1995 | 12-1994 | 12-1993 | 12-1992 | 12-1991 | |
| Sales | 27,385 | 23,192 | 7,092 | 6,554 | 7,313 |
| Gross Profit | 27,385 | 23,192 | 7,092 | 6,554 | 7,313 |
| Operating Expenses | 48,765 | 52,444 | 49,395 | 29,913 | 16,887 |
| Operating Income | -21,380 | -29,252 | -42,302 | -23,359 | -9,574 |
| Interest Expense | 1,205 | 1,403 | 1,046 | 736 | 89 |
| Other Income | -922 | 0 | 3,464 | 4,982 | 5,195 |
| Pre-tax Income | -23,507 | -30,655 | -39,884 | -19,113 | -4,468 |
| Net Income Continuous | -22,915 | -30,655 | -39,884 | -19,113 | -4,468 |
| Net Income | $-23,507 | $-30,655 | $-39,884 | $-19,113 | $-4,468 |
| EPS Basic Total Ops | -1.19 | -1.62 | -2.41 | -1.24 | -0.35 |
| EPS Basic Continuous Ops | -1.16 | -1.62 | -2.12 | -1.25 | -0.29 |
| EPS Diluted Total Ops | -1.19 | -1.62 | -2.41 | -1.25 | -0.29 |
| EPS Diluted Continuous Ops | -1.16 | -1.62 | -2.12 | -1.25 | -0.29 |
| EBITDA(a) | $-15,525 | $-25,157 | $-39,201 | $-21,249 | $-8,795 |